•
Sep 30, 2022

Acadia Healthcare Q3 2022 Earnings Report

Acadia Healthcare reported strong third-quarter results, driven by robust demand and strategic investments.

Key Takeaways

Acadia Healthcare reported a revenue increase of 13.5% to $666.7 million, with same-facility revenue growth of 10.2%. Net income attributable to Acadia totaled $71.1 million, or $0.78 per diluted share, and adjusted income from continuing operations was $73.3 million, or $0.86 per diluted share.

Revenue totaled $666.7 million, an increase of 13.5% over the third quarter of 2021.

Same facility revenue increased 10.2% compared to the third quarter of 2021, including an increase in revenue per patient day of 6.9% and an increase in patient days of 3.1%.

Net income attributable to Acadia totaled $71.1 million, or $0.78 per diluted share.

Adjusted income from continuing operations attributable to Acadia stockholders totaled $73.3 million, or $0.86 per diluted share, which included $0.06 of income from the Provider Relief Fund.

Total Revenue
$667M
Previous year: $588M
+13.5%
EPS
$0.8
Previous year: $0.72
+11.1%
US Same Facility Revenue Growth
10.2%
Previous year: 7.9%
+29.1%
US Same Facility Patient Days Growth
3.1%
Previous year: 2.2%
+40.9%
US Rev. per Patient Day Growth
6.9%
Previous year: 5.6%
+23.2%
Gross Profit
$289M
Previous year: $255M
+13.3%
Cash and Equivalents
$93.4M
Previous year: $196M
-52.4%
Free Cash Flow
-$35.3M
Previous year: $66.4M
-153.1%
Total Assets
$4.94B
Previous year: $4.59B
+7.6%

Acadia Healthcare

Acadia Healthcare

Forward Guidance

Acadia narrowed its previously announced financial guidance for 2022.